Your institution may have access to this item. Find your institution then sign in to continue.
Title
Withdrawals from the market.
Abstract
This section offers news briefs on drug withdrawals from the market as of April 2016. Last marketing authorization for the sedative medicine meprobamate has been canceled in Great Britain. The marketing authorization for fusafungine-containing products in the European Union has been cancelled. The U.S. Food and Drug Administration has rescinded its approval of the use of the veterinary drug carabadox to treat pigs.